Umcka Menthol (pelargonium sidoides) NDC 53499-5272

NDC codes

FDA NDC Directory

Product NDC (as listed)53499-5272Labeler and product segments. Claims need a package NDC.

Product NDC at billing width53499-5272Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
53499-5272-5	53499527205	1 BOTTLE, PLASTIC in 1 CARTON (53499-5272-5) / 120 mL in 1 BOTTLE, PLASTICMarketed from Jan 1, 2006
53499-5272-9	53499527209	1 BOTTLE, PLASTIC in 1 CARTON (53499-5272-9) / 240 mL in 1 BOTTLE, PLASTICMarketed from Jan 1, 2006

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Umcka Menthol
Generic name (nonproprietary): pelargonium sidoides
Active ingredients: Pelargonium sidoides root — 1 [hp_X]/120mL
Dosage form: Syrup
Route: Oral
Labeler: Schwabe North America, Inc
Product type: Over-the-counter drug
Marketing category: Unapproved homeopathic
Marketing start: Jan 1, 2006
Marketing end: Jul 31, 2027
Identifiers: Product ID 53499-5272_85ee5b28-643c-448d-ad9e-961f27b2622eSPL ID 85ee5b28-643c-448d-ad9e-961f27b2622eSPL set ID a3d94c70-3d62-44a8-bdae-39b07e8e0e36UNII H6J53HEX8EUPC 0033674152720

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N453499527205 followed by a unit qualifier and the quantity

Package 53499-5272-05. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Nov 24, 2025.

Indications (excerpt from the label)

Indications & Usage Shortens duration and reduces severity of symptoms associated with common colds and throat/nasal/bronchial irritations: congestion, cough, hoarseness, sore throat.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)